Current good manufacturing practices establish uniform standards to ensure quality throughout the manufacturing, packaging, labeling, and holding of OTC medicines and dietary supplement products.
CHPA opposes mandatory manufacturer-funded drug take-back programs as they threaten the affordability of OTC medications that consumers rely on as the first line of defense against common ailments.
Up and Away reminds families of the importance of safe medicine storage to prevent young children from accidentally getting into medicine. It is led by the CDC and Health in Hand, in partnership with the PROTECT Initiative.
Acetaminophen is a safe OTC analgesic that's widely used by adults and children when following recommended dosage guidelines. Lawmakers should oppose restrictions to access for either age group, as drug regulatory entities already actively monitor research and update consumer protections.
Lawmakers should refrain from imposing unnecessary access barriers to diphenhydramine, as leading manufacturers continuously assess and implement efforts to curb teen abuse without limiting adult availability.
Manufacturers have developed an anti-smurfing educational program for the retail setting that is voluntary and offered to retailers at no cost. The intent is to educate potential illegal purchasers about related criminal penalties and how the real-time, stop-sale system works.
This proposed safety administrative order addresses the GRASE status of OTC oral health care drug products containing benzocaine alone or with phenol preparations labeled for anesthetic/analgesic indications (21 CFR 356).
